Failure to obtain drug-resistant variants of influenza virus after treatment with inhibiting doses of 3-deazaadenosine and H 7 (original) (raw)

Summary

3-Deazaadenosine and H 7 specifically inhibit influenza virus replication under conditions at which they have no effect on other tested RNA viruses. This effect can be significantly potentiated by concomitant application of both compounds. Even under the most stringent conditions we failed to obtain any drug resistant variants. A possible explanation for this failure is that these compounds presumably do not act on a viral component like amantadine which was used as a control, but they interfere with cellular enzymes (factors) absolutely essential for influenza virus replication but more or less dispensable for the survival of the cell.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Backlund PS, Carotti D, Cantoni GL (1986) Effects of the 5-adenosylhomocysteine hydrolase inhibitors 3-deazaadenosine and 3-deazaaristeromycin on RNA methylation and synthesis. Eur J Biochem 160: 245–251
    Google Scholar
  2. Fischer AAH, Müller K, Scholtissek C (1990) Specific inhibition of the synthesis of influenza virus late proteins and stimulation of early, M 2, and NS 2 protein synthesis by 3-deazaadenosine. Virology 177: 523–531
    Google Scholar
  3. Hay AJ, Wolstenholme AJ, Skehel JJ, Smith MH (1985) The molecular basis of the specific anti-influenza action of amantadine. EMBO J 4: 3021–3024
    Google Scholar
  4. Hidaka H, Inagaki M, Kawamoto S, Sasaki Y (1984) Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 23: 5036–5041
    Google Scholar
  5. Kistner O, Müller K, Scholtissek C (1989) Differential phosphorylation of the nucleoprotein of influenza A viruses. J Gen Virol 70: 2421–2431
    Google Scholar
  6. Klenk HD, Rott R, Becht H (1972) On the structure of the influenza virus envelope. Virology 48: 579–591
    Google Scholar
  7. Krug RM, Morgan MM, Shatkin AJ (1976) Influenza viral mRNA contains internal N 6-methyladenosine and 5′-terminal 7-methylguanosine in cap structure. J Virol 20: 45–53
    Google Scholar
  8. Parvin JD, Moscona A, Pan WT, Leider JM, Palese P (1986) Measurement of the mutation rates of animal viruses: influenza A virus and poliovirus type 1. J Virol 59: 377–383
    Google Scholar
  9. Steinhauer DA, Holland JJ (1987) Rapid evolution of RNA viruses. Annu Rev Microbiol 41: 409–433
    Google Scholar
  10. Steinhauer DA, DeLa Torre JC, Holland JJ (1989) High nucleotide substitution error frequencies in clonal pools of vesicular stomatitis virus. J Virol 63: 2063–2071
    Google Scholar
  11. Von Magnus P (1954) Incomplete forms of influenza virus. Adv Virus Res 2: 59–79
    Google Scholar
  12. Webster RG, Bean WJ (1987) Antiviral compounds for treatment of highly pathogenic avian influenza. In: Alexander DJ, Beard CW (eds) Proceedings of the Second International Symposium on Avian Influenza. Extension Duplicating Services, University of Wisconsin, Madison, WI, pp 293–301
    Google Scholar

Download references

Author information

Authors and Affiliations

  1. Institut für Virologie, Justus-Liebig-Universität Giessen, Giessen, Germany
    C. Scholtissek & Karin Müller

Authors

  1. C. Scholtissek
  2. Karin Müller

Rights and permissions

About this article

Cite this article

Scholtissek, C., Müller, K. Failure to obtain drug-resistant variants of influenza virus after treatment with inhibiting doses of 3-deazaadenosine and H 7.Archives of Virology 119, 111–118 (1991). https://doi.org/10.1007/BF01314327

Download citation

Keywords